Purpose To make recommendations regarding the use of bisphosphonates and other bone-
modifying agents as adjuvant therapy for patients with breast cancer. Methods Cancer Care …

Background: Osteoporosis is a major contributor to the propensity to fracture among older
adults, and various pharmaceuticals are available to treat it. Purpose: To update a review …

Resumen La Asociación Colombiana de Osteoporosis y Metabolismo Mineral se reunió a
principios de 2017 para actualizar el Consenso Colombiano de Osteoporosis, elaborado …

In rare cases, bisphosphonates are well established to cause ocular inflammation,
presenting as uveitis, episcleritis, scleritis, orbital inflammation, and/or conjunctivitis. Some …

National registers showed that a large proportion of patients treated with strontium ranelate
have conditions that may now contraindicate use. The risk of death in strontium ranelate …

Randomized controlled trials have demonstrated the efficacy of bisphosphonates (BP) in
improving BMD and reducing fracture risk. Various safety issues that were not noted in …

The ever-broadening scope of pharmaceuticals now available to treat previously untreatable
conditions, such as advanced metastatic cutaneous melanoma, have resulted in unintended …

Abstract Background Bisphosphonates (BPs) are pyrophosphate analogues widely used in
diseases related to bone loss and increased bone turnover. Their high affinity for bone …

Objectives: Summarize the mechanism of action of bisphosphonates. Identify the approved
indications for bisphosphonate therapy. Review the potential adverse events for …

OBJECTIVES Vision and hearing impairment may impact both life expectancy (LE) and
health expectancy, that is, duration of life with and without health problems, among older …